BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 713028)

  • 1. The metabolism of digitoxin in hepatic cirrhosis of human subjects.
    Hamamoto H; Takeda H; Katoh T; Tokuoka T; Kitamura K; Takanashi T; Bamba M
    Jpn Circ J; 1978 Jul; 42(7):893-900. PubMed ID: 713028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man.
    Caldwell JH; Bush CA; Greenberger NJ
    J Clin Invest; 1971 Dec; 50(12):2638-44. PubMed ID: 5129315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of quinidine on pharmacokinetics and pharmacodynamics of digitoxin achieving steady-state conditions.
    Kuhlmann J; Dohrmann M; Marcin S
    Clin Pharmacol Ther; 1986 Mar; 39(3):288-94. PubMed ID: 3512148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and bioavailability of digitoxin by a specific assay.
    MacFarland RT; Marcus FI; Fenster PE; Graves PE; Perrier D
    Eur J Clin Pharmacol; 1984; 27(1):85-9. PubMed ID: 6489430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digitoxin in patients with hepatorenal insufficiency after repeated oral administration.
    Kirch W; Ohnhaus EE; Pabst J; Storstein L
    Eur Heart J; 1989 Jan; 10(1):40-7. PubMed ID: 2702965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of digitoxin in chronic renal failure (author's transl)].
    Peters U; Grabensee B; Hausamen TU; Fritsch WP; Grosse-Brockhoff F
    Dtsch Med Wochenschr; 1977 Jan; 102(4):109-15. PubMed ID: 832589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digitoxin kinetics and renal excretion in children.
    Larsen A; Storstein L
    Clin Pharmacol Ther; 1983 Jun; 33(6):717-26. PubMed ID: 6851404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serial tests of serum-digitoxin levels during digitoxin treatment (author's transl)].
    Peters U; Hausamen TU; Grosse-Brockhoff F
    Dtsch Med Wochenschr; 1974 Aug; 99(35):1701-7. PubMed ID: 4410846
    [No Abstract]   [Full Text] [Related]  

  • 9. Digitoxin and its metabolites in patients with liver cirrhosis.
    Nokhodian A; Santos SR; Kirch W
    Eur J Drug Metab Pharmacokinet; 1993; 18(2):207-13. PubMed ID: 8243505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The absorption of digitoxin in patients with acute and chronic diarrhea.
    Takanashi T; Katoh T; Takeda H; Tokuoka T; Hamamoto H; Kitamura K
    Jpn Circ J; 1978 Jul; 42(7):849-53. PubMed ID: 713024
    [No Abstract]   [Full Text] [Related]  

  • 11. Digitoxin accumulation.
    Ochs HR; Pabst J; Greenblatt DJ; Hartlapp J
    Br J Clin Pharmacol; 1982 Aug; 14(2):225-9. PubMed ID: 7104174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability and elimination of digitoxin in patients with hepatorenal insufficiency.
    Kirch W; Ohnhaus EE; Dylewicz P; Pabst J; Storstein L
    Am Heart J; 1986 Feb; 111(2):325-9. PubMed ID: 3946177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on digitalis. III. Biliary excretion and enterohepatic circulation of digitoxin and its cardioactive metabolites.
    Storstein L
    Clin Pharmacol Ther; 1975 Mar; 17(3):313-20. PubMed ID: 1120397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of antituberculosis drugs on the pharmacokinetics of digitoxin (author's transl)].
    Peters U; Hausamen TU; Grosse-Brockhoff F
    Dtsch Med Wochenschr; 1974 Nov; 99(47):2381-6. PubMed ID: 4426257
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in normal subjects.
    Graves PE; Fenster PE; MacFarland RT; Marcus FI; Perrier D
    Clin Pharmacol Ther; 1984 Nov; 36(5):601-6. PubMed ID: 6488680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on digitalis. VII. Influence of nephrotic syndrome on protein binding, pharmacokinetics, and renal excretion of digitoxin and cardioactive metabolites.
    Storstein L
    Clin Pharmacol Ther; 1976 Aug; 20(2):158-66. PubMed ID: 947651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gycoside serum concentrations under maintenance therapy with Lanicor, Card-Lamuran, MF708d, and Lanitop (author's transl)].
    Weiss W; Olcay A; Teufel W; Glocke M
    Med Klin; 1975 Aug; 70(35):1367-74. PubMed ID: 809651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of phenobarbital on digitoxin and digoxin elimination in the dog.
    Breznock EM
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):371-3. PubMed ID: 1124874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, bioavailability and serum levels of cardiac glycosides.
    Smith TW
    J Am Coll Cardiol; 1985 May; 5(5 Suppl A):43A-50A. PubMed ID: 3921586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninteraction of digitoxin and quinidine.
    Ochs HR; Pabst J; Greenblatt DJ; Dengler HJ
    N Engl J Med; 1980 Sep; 303(12):672-4. PubMed ID: 7402253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.